Family Medicine·Bryn Mawr, PA

Main Line Health System/Bryn Mawr Hospital

Signal lift63%85%+22 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
219–263
p10 – p90
Sample N
537
applicants this cycle
This cycle
no tracked aways yet
Match rate
0.9%
5 of 71 applicants
01Cohort funnelthis cycle
N = 537
Applied
537
100.0%
Invited
71
13.2%
Class size
5
0.9%
J-1 visaH-1B visaCategorical
Your fitMain Line Health System/Bryn Mawr Hospital Program

Create a free profile to see your personalized fit

Get started
Contact
CB
Program Director
Christine Ann Black-Langenau, DO
Email director
CB
Program Coordinator
Christina Bouikidis
Email coordinator
Training sites2 hospitals
  • 1
    Bryn Mawr Hospital
    Bryn Mawr, PA
    Primary
  • 2
    Main Line Health System
    Wynnewood, PA
    Sponsor
Score rangesinvited cohort
USMLE Step 2 CK219263
180205230255280

Level 2 CE data not available

Interview rates
US MD
49%
US DO
11%
US IMG
0%
Non-US IMG
0%
Applicant origin
In-state
43%
Out-of-state
7%
Interview prepFamily Medicine
specialtyWhat attracts you to the breadth of family medicine?★ common
programRural vs urban practice — what's your preference?
clinicalHow do you approach continuity of care?
specialtyTell me about procedures you'd like to incorporate into your practice.
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesFamily Medicine · 25-26
Save this program

Add Main Line Health System/Bryn Mawr Hospital to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Family Medicine.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.